| 000 | 00966 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516161254.0 | ||
| 264 | 0 | _c20140213 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc.13.95 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMatthiessen, Line | |
| 245 | 0 | 0 |
_aInterview with Line Matthiessen. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _cJul 2013 |
||
| 300 |
_a1199-201 p. _bdigital |
||
| 500 | _aPublication Type: Interview | ||
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCommunicable Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeglected Diseases _xdrug therapy |
| 650 | 0 | 4 | _aPublic Health |
| 650 | 0 | 4 | _aResearch |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 5 _gno. 11 _gp. 1199-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc.13.95 _zAvailable from publisher's website |
| 999 |
_c22921721 _d22921721 |
||